StocktoriaMANGOCEUTICALS, INC. MGRX
Nasdaq · XNAS · stock · Services-Misc Health & Allied Services, NEC
Chart by TradingView
2/9
Piotroski F — financial health
2.42
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | $456,021 | $615,873 | $731,493 | $8,939 |
| Gross profit | $250,386 | $379,964 | $431,501 | $4,850 |
| Operating income | -$18.0M | -$8.0M | -$9.2M | -$2.0M |
| Net income | -$20.6M | -$8.7M | -$9.2M | -$2.0M |
| Operating cash flow | -$5.9M | -$4.9M | -$7.0M | -$1.3M |
| Free cash flow | — | — | -$7.0M | -$1.4M |
| Total assets | $16.1M | $15.4M | $1.1M | $1.0M |
| Total liabilities | $890,568 | $1.4M | $276,039 | $389,257 |
| Shareholders' equity | $15.2M | $13.9M | $774,754 | $614,029 |
| Ratios | ||||
| Gross margin | 54.9% | 61.7% | 59.0% | 54.3% |
| Operating margin | -3954.3% | -1294.4% | -1260.3% | -22279.7% |
| Net margin | -4526.8% | -1413.6% | -1259.4% | -22352.1% |
| FCF margin | — | — | -957.1% | -15545.6% |
| Return on assets | -128.3% | -56.6% | -876.7% | -199.2% |
| Return on equity | -135.8% | -62.4% | -1189.1% | -325.4% |
| Current ratio | 1.74 | 0.05 | 3.96 | 2.67 |
| Revenue growth | -26.0% | -15.8% | 8083.2% | — |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.42 (grey)
- Working capital / assets 0.041
- Retained earnings / assets -2.526
- EBIT / assets -1.121
- Equity / liabilities 17.067
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001938046 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.